Optimal Fasting Insulin: Ranges, HOMA-IR, and Why Lab-Normal Is Not Optimal

The optimal fasting insulin level is below 5 µIU/mL (35 pmol/L). A result of 5–8 µIU/mL is acceptable, 8–15 µIU/mL points to early insulin resistance, and anything above 15 µIU/mL is high. Most labs, however, use a reference range of roughly 2.6–24.9 µIU/mL and only flag results above about 25 — five times the optimal ceiling. That gap matters because fasting insulin is one of the earliest measurable warnings of metabolic dysfunction: it starts climbing years, often more than a decade, before fasting glucose or HbA1c drift out of the normal range.

To convert µIU/mL to pmol/L, multiply by 6.945. Pair insulin with fasting glucose to compute HOMA-IR (homeostatic model assessment of insulin resistance): HOMA-IR = fasting glucose (mg/dL) × fasting insulin (µIU/mL) ÷ 405. With glucose in mmol/L, divide by 22.5 instead of 405.

What does fasting insulin measure — and why does it rise years before glucose?

Insulin is the hormone that moves glucose out of your blood into muscle, liver, and fat cells. A fasting insulin test measures how much of it your pancreas must secrete just to hold blood glucose steady after an overnight fast. Low insulin with normal glucose means your cells respond easily; high insulin with normal glucose means your pancreas is working overtime to force the same result.

That is why insulin moves first. As muscle and liver become resistant, the pancreas compensates by secreting more insulin, and glucose stays deceptively normal — sometimes for decades. In the Whitehall II cohort, people who went on to develop type 2 diabetes already had measurably lower insulin sensitivity more than a decade before diagnosis, while their fasting glucose rose steeply only in the final 2–3 years. Similarly, an analysis of the Kraft database of oral glucose tolerance tests found that just over half of people with completely normal glucose tolerance still showed a hyperinsulinaemic response — insulin resistance hidden behind normal glucose numbers.

In short: glucose is the value your body defends; insulin is the price it pays to defend it. The price rises long before the defense fails.

What is the optimal fasting insulin level vs the lab-normal range?

Lab reference ranges are statistical, not aspirational: they describe roughly the middle 95% of the tested population — a population in which insulin resistance is very common. That is how a fasting insulin of 20 µIU/mL can come back without a flag while being four times the optimal level. Most labs only flag results above about 25 µIU/mL (174 pmol/L), which is closer to established metabolic disease than to an early warning.

The case for aiming below 5–8 µIU/mL: hyperinsulinaemia predicts trouble on its own. In the Helsinki Policemen Study, nearly 1,000 healthy middle-aged men were followed for 22 years; those with the highest insulin levels had a significantly higher risk of major coronary events, independent of glucose, cholesterol, blood pressure, and BMI. Chronically high insulin also travels with high triglycerides, low HDL, and a higher count of atherogenic particles — if you monitor lipids, pair this marker with ApoB.

Honest caveat: no randomized trial has tested whether lowering fasting insulin per se prevents heart attacks. The evidence is associative plus mechanistic — strong enough to watch the marker closely, not strong enough to promise outcomes.

Is my fasting insulin of 8 a problem?

A fasting insulin of 8 µIU/mL (56 pmol/L) is not an emergency and sits comfortably inside every lab reference range. It is, however, exactly at the boundary where early insulin resistance typically begins — the top of the acceptable band, not the middle of the optimal one.

Context decides the verdict. At 8 µIU/mL with fasting glucose of 85 mg/dL (4.7 mmol/L), HOMA-IR is 1.7 — typical. The same insulin with glucose at 100 mg/dL (5.6 mmol/L) gives 2.0 — the early-resistance threshold. Waist circumference, triglycerides, blood pressure, and family history push the interpretation one way or the other.

Also know that fasting insulin is a noisy marker: day-to-day swings of 20–30% are common, so a single 8 could read 6 or 10 on another morning. Retest before drawing conclusions, and judge the trend over months rather than any single draw. Logging each result in BioTrakk turns scattered lab PDFs into one trend line you can actually act on.

How do you calculate HOMA-IR — and what is the optimal range?

HOMA-IR was introduced by Matthews and colleagues in 1985 to estimate insulin resistance from a single fasting sample. The formula: fasting glucose (mg/dL) × fasting insulin (µIU/mL) ÷ 405. Worked example: glucose 95 mg/dL × insulin 8 µIU/mL = 760; 760 ÷ 405 = 1.9. In SI units: glucose (mmol/L) × insulin (µIU/mL) ÷ 22.5.

The optimal HOMA-IR range is below 1.0. Between 1.0 and 1.9 is typical, 2.0–2.9 signals early insulin resistance, and 2.9 or above indicates significant resistance. Population data broadly agree: in the Spanish EPIRCE study, the HOMA-IR cut-offs associated with metabolic syndrome fell between roughly 2 and 3.9 depending on age and sex.

Know its limits: HOMA-IR mainly reflects fasting (hepatic) insulin resistance and misses post-meal dysfunction; it is not valid if you inject insulin; and insulin assays are not fully standardized between manufacturers, so always compute it from results drawn at the same lab.

Fasting insulin vs HbA1c vs OGTT: which matters most?

These tests answer different questions. HbA1c is excellent for diagnosing and managing established diabetes, but it is a lagging indicator: it summarizes glucose, and glucose is the last domino to fall. It can also mislead when red-cell lifespan is unusual (anemia, recent blood loss, some hemoglobin variants). The oral glucose tolerance test with insulin measurements — the Kraft protocol — is the most sensitive way to unmask hidden hyperinsulinaemia, but a multi-hour, multi-draw test is impractical for routine tracking.

Practical hierarchy for self-trackers: use fasting insulin plus HOMA-IR for early detection and trend tracking, HbA1c to confirm where average glucose actually stands, and a full OGTT only if the two disagree or your clinician wants dynamic data.

How do you lower fasting insulin?

Four interventions have solid randomized or meta-analytic evidence:

• Resistance training. A meta-analysis of randomized trials in people with abnormal glucose metabolism found resistance training significantly improved glycemic control and insulin sensitivity markers. Muscle is your largest glucose sink; 2–3 full-body sessions per week grow it.
• Weight loss if you carry excess fat. In the DiRECT trial, 86% of participants who lost 15 kg or more put type 2 diabetes into remission within a year — the strongest demonstration that insulin-glucose dysfunction is reversible. Even 5–10% of body weight measurably improves insulin sensitivity.
• Sleep. A single night of four hours of sleep reduced insulin sensitivity by roughly 20–25% in healthy adults in a controlled clamp study. Chronic short sleep keeps insulin demand elevated; 7–9 hours is a metabolic intervention, not a luxury.
• Low-glycemic eating. A 2019 systematic review and meta-analysis of randomized trials (Zafar et al., Am J Clin Nutr) found low-GI diets modestly but significantly reduced HbA1c, fasting glucose, and body weight versus higher-GI comparison diets.

Responses differ between individuals — which is exactly what an n-of-1 experiment is for: pick one intervention, run it for 8–12 weeks against your baseline, then retest. BioTrakk structures this as a baseline phase, an intervention phase, and a significance-tested verdict — including an honest inconclusive when the data does not support a claim.

How often should you retest fasting insulin — and under what conditions?

Test conditions matter more for insulin than for most blood markers:

• A true fast: 10–12 hours with water only. Milk in your coffee or a late-night snack invalidates the draw.
• No morning exercise before the draw: a workout acutely shifts glucose uptake and insulin dynamics; train after the blood test, not before.
• Normal sleep the night before: one short night can depress insulin sensitivity by around 20–25% and inflate your result.
• Morning draw at a consistent time: the natural morning cortisol surge nudges glucose upward, so an 8 a.m. and a noon sample are not comparable — see how cortisol varies across the day.
• Same lab, same assay: insulin assays differ between manufacturers; switching labs can move your number without your body changing.
• Not during illness or unusual stress: both raise insulin transiently.

Frequency: every 3–6 months while actively intervening — 8–12 weeks is roughly the minimum for training, diet, or weight changes to show up in the number — and once a year for maintenance. Log each result with the test conditions in BioTrakk so you can separate real change from noise.